PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
Author(s) -
William M. Wood,
Vibha Sharma,
Kevin T. Bauerle,
Laura A. Pike,
Qiong Zhou,
Deborah Fretwell,
Rebecca E. Schweppe,
Bryan R. Haugen
Publication year - 2011
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2011/171765
Subject(s) - cancer research , cell growth , thyroid cancer , thyroid , peroxisome proliferator activated receptor , anaplastic thyroid cancer , medicine , algorithm , endocrinology , receptor , chemistry , mathematics , biochemistry
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPAR γ levels are elevated in cells derived from ATC. Depletion of PPAR γ in HTh74 ATC cells resulted in decreased cell growth, cell cycle arrest and a reduction in pRb and cyclin A and B1 levels. We further showed that both flank and orthotopic thyroid tumors derived from PPAR γ -depleted cells grew more slowly than PPAR γ -expressing cells. When PPAR γ was overexpressed in more differentiated thyroid cancer BCPAP cells which lack PPAR γ , there was increased growth and raised pRb and cyclin A and B1 levels. Finally, PPAR γ depletion in ATC cells decreased their invasive capacity whereas overexpression in PTC cells increased invasiveness. These data suggest that PPAR γ may play a detrimental role in thyroid cancer and that targeting it therapeutically may lead to improved treatment of advanced thyroid cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom